The two most powerful tools in the treatment of psychiatric disorders are psychopharmacology and psychotherapy. In most cases, patients greatly benefit from a combination of both; however, due to increasing specialisation, this is less and less provided by the same therapist. Instead, medical professionals such as psychiatrists often tend to focus more on treatment strategies based on drugs, whereas psychologists emphasise psychotherapeutic approaches. Therefore, close collaboration is required between the different therapists involved in the treatment of one psychiatric patient.
In the past years, the number of drugs used in psychiatry has expanded considerably. At the same time, a plethora of different techniques have been developed in the field of psychotherapy. Furthermore, while monotherapy with just one specific psychotropic substance is desirable, many patients need a combination of different drugs because of the severity of their symptoms. Similarly, modern psychotherapy typically does no longer adhere to just one ''school of thinking'', but rather favours an eclectical approach combining different techniques of various methods, depending on the needs of each individual patient.
The clinically important issue of combining psychotherapy with pharmacological strategies is reflected in an ever increasing body of publications reviewing the stateof-the art in the treatment of stress and trauma, depressive disorders, anxiety disorders, dissociative disorders, personality disorders, post-traumatic stress-disorder (PTSD) and other neuropsychiatric conditions (Pratchett et al. 2011; von Wolff et al. 2012; Cuijpers et al. 2013; Gentile et al. 2013 Gentile et al. , 2014 Lam et al. 2013; Huhn et al. 2014; Zilcha-Mano et al. 2014; Hersh 2015) .
During the 11th Hanse symposium which took place in Rostock from 7 to 8 September 2013, experts in the field discussed the possibilities of an improved integration of psychotherapy and pharmacotherapy, contributing with key lectures entitled ''Optimizing treatments of schizophrenia and mechanism of antipsychotic drugs'', ''The role of natural medicine in psychiatry'', ''Chronotherapy in affective disorders and dementia'', ''ADHD medication and its effects on the brain'', ''Caveats of combination therapy'', ''ACT (acceptance and commitment therapy), the third wave of behavioural therapy'', ''ACT for inpatients'', ''ACT in the preparation of teachers for an inclusion setting'', ''ACT and its noble kinsmen''.
For this supplement, additional authors contributed, discussing various aspects such as ''Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease With these contributions, the authors have considerably enlarged the thematic field on which the symposium had originally focused. Nevertheless, this collection of papers gives a fascinating overview of present-day developments in psychiatry and on how fundamental as well as clinical research can contribute to improving patients' condition.
